Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...

German life sciences giant Bayer believes a change to EU policy on gene-edited crops has the potential to reshape Europe’s ...

Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company’s shares and piling pressure on its CEO to ...

LEVERKUSEN, Germany--(BUSINESS WIRE)--The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of ...

Bayer und Microsoft schlie..en strategische Partnerschaft, um die Digitalisierung der Wertsch..pfungskette f..r Lebensmittel voranzubringen.-----.Bayer and Microsoft enter into strategic partnership ...

Bayer AG and ADM extend their partnership to support 100,000 soybean farmers in Maharashtra, India, quadrupling the program's ...

Bayer AG is a $50-billion multinational life sciences conglomerate based in Germany. The company is trading at a discount of at least 20% compared to its peers as well as to its historical multiples.